Intrapleural fibrinolytic therapy (IPFT) in loculated pleural effusions-analysis of predictors for failure of therapy and bleeding: A cohort study

BMJ Open

Volumn 3, Issue 2, 2013, Pages

  Abu Daff, Saleh ^a   Maziak, Donna E ^a   Alshehab, Derar ^a   Threader, Jennifer ^a   Ivanovic, Jelena ^a   Deslaurier, Valerie ^a   Villeneuve, Patrick James ^a   Gilbert, Sebastian ^a   Sundaresan, Sudhir ^a   Shamji, Farid ^a   Lougheed, Colleen ^a   Seely, Jean M ^a   Seely, Andrew J E ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTIPYRETIC AGENT; CLOPIDOGREL; NAPROXEN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BLEEDING; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DEMOGRAPHY; DRUG EFFICACY; DRUG TREATMENT FAILURE; DYSPNEA; EMPYEMA; FEMALE; FEVER; FIBRINOLYTIC THERAPY; HEMATOTHORAX; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG CANCER; LUNG LOBECTOMY; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MALIGNANT EFFUSION; MEDICAL RECORD REVIEW; PLEURA EFFUSION; PROTHROMBIN TIME; RETROSPECTIVE STUDY; RISK FACTOR;

EID: 84875127913     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-001887     Document Type: Article

References (22)

1. Cohen M, Sahn SA. Resolution of pleural effusions. Chest 2001;119:1547-62. (Pubitemid 32686042)
2. Taryl DA, Potts DE, Sahn SA. The incidence and clinical correlates of para-pneumonic effusions in pneumococcal pneumonia. Chest 1978;74:170-3. (Pubitemid 8404854)
3. Light RW. Pleural diseases. Philadelphia, PA: Lippincott, Williams & Wilkins, 2001;151-81.
4. Chung C-L, Chen Y-C, Chang S-C. Effect of repeated thoracentesis on fluid characteristics, cytokines and fibrinolytic activity in malignant pleural effusion. Chest 2003;123:1188-95. (Pubitemid 36444377)
5. Savi A, Nemec AA Jr. The use of fibrinolytic agents in drainage of complicated fluid collections. Appl Radio 1998;27:43-9.
6. Strange C, Allen ML, Harley R, et al. Intrapleural streptokinase in expiremental empyema. Am Rev Respir Dis 1993;147:962-6.
7. Meier AH, Smith B, Raghavan A, et al. Rational of treatment of empyema in children. Arch Surg 2000;135:907-13.
8. Bishop NB, Pon S, Ushag HM, et al. Altaplase in the treatment of complicated pneumonic effusion. Chest 1990;90:852-6.
9. Tillet WS, Sherry S. The effect in patients with streptococcal fibrinolysis purulent, and sanguinous pleural exudations. J Clin invest 1949;28:173-90.
10. Bergh NP, Ekroth R, Larson S, et al. Intra pleural strepto-kinase in the treatment of hemothorax and empyema. Scand J Cardiovasc Surg 1977;11:265-8.
11. Davis RJ, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax 1997;52:416-21.
12. Bouros D, Schiza S, Tzanakis N, et al. Intrapleural urokinase versus normal saline in the treatment of complicated para-pneumonic effusions and empyema. Am J Respir Crit Care Med 1999;159:37-42. (Pubitemid 29036500)
13. Bouros D, Schiza S, Patsourakis G, et al. Intra pleural strepto-kinase versus urokinase in the treatment of complicated para-pneumonic effusions: prospective double-blind study. Am J Respir Crit Care Med 1997;155:291-5. (Pubitemid 27053179)
14. Thompson AH, Hull J, Kumar MR, et al. Randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax 2002;57:343-7. (Pubitemid 34298933)
15. Diacon AH, Theron J, Schuuramans MM, et al. Intrapleural streptokinase for empyema and complicated parapneumonic effusions . Am J Respir Crit Care Med 2004;170:49-53. (Pubitemid 38997750)
16. Maskell NA, Davis CWH, Nunn AJ, et al. Controlled trial of intra pleural streptokinase for pleural infection. N Eng J Med 2005;352:865-74. (Pubitemid 40300295)
17. Cameron RJ, Davies H. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and Empyema. Cochrane Library 2009;3:1-42.
18. Rahman N, Maskell NA, West A, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med 2011;365:518-26.
19. Skeete DA, Rutherford EJ, Schlidt SA, et al. Intrapleural tissue plasminogen activator for complicated pleural effusions. J Trauma 2004;57:1178-83. (Pubitemid 40053810)
20. Thommi G, Chandra KN, Aronow WS, et al. Efficacy and safety of intrapleural instillation of Alteplase in the management of complicated pleural effusion or empyema. Am J Ther 2007;14:341-5. (Pubitemid 47220844)
21. Froudarakis ME, Kouliatsis G, Steiropoulos P, et al. Recombinant tissue plasminogen activator in the treatment of pleural infections in adults. Respir Med 2008;102:1694-700.
22. Activase (Alteplase, recombinant tissue plasminogen activator) prescribing information. South San Francisco, CA: Genentech, Inc. Revised 1999.